CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-31 | Tarriff Scott Director | Grant or award · Stock Option (right to buy) | +50,562 | 50,562 | ||
| 2019-12-31 | Pagan Douglas W. Director | Grant or award | +15,890 | 55,997 | ||
| 2019-12-31 | Pagan Douglas W. Director | Shares withheld for taxes | −20,054 | $4.72 | $95K | 35,943 |
| 2019-12-31 | Pagan Douglas W. Director | Grant or award · Stock Option (right to buy) | +25,281 | 25,281 | ||
| 2019-12-31 | Lafond Kevin G SVP, Treasurer & CAO | Grant or award · Employee Stock Option (right to buy) | +48,000 | 48,000 | ||
| 2019-12-31 | Hagen Heidi Director | Grant or award | +31,780 | 32,119 | ||
| 2019-12-31 | Ezickson Elan Director | Grant or award | +31,780 | 111,994 | ||
| 2019-12-31 | Ezickson Elan Director | Shares withheld for taxes | −40,107 | $4.72 | $189K | 71,887 |
| 2019-12-31 | Braunstein Scott Director | Grant or award | +31,780 | 31,780 | ||
| 2019-12-31 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +50,562 | 50,562 | ||
| 2019-12-30 | Cooper Laurence James Neil Chief Executive Officer | Sale | −110,694 | $4.88 | $540K | 1,733,273 |
| 2019-12-27 | Cooper Laurence James Neil Chief Executive Officer | Option exercise | +44,642 | $2.24 | $100K | 1,843,967 |
| 2019-12-27 | Cooper Laurence James Neil Chief Executive Officer | Option exercise · Employee Stock Option (right to buy) | −44,642 | 487,171 | ||
| 2019-11-26 | Lafond Kevin G SVP, Treasurer & CAO | Option exercise | +11,667 | $2.85 | $33K | 97,222 |
| 2019-11-26 | Lafond Kevin G SVP, Treasurer & CAO | Sale | −11,667 | $5.25 | $61K | 85,555 |
| 2019-11-26 | Lafond Kevin G SVP, Treasurer & CAO | Option exercise · Employee Stock Option (Right to Buy) | −11,667 | 0 | ||
| 2019-10-25 | Bowden Christopher Director | Grant or award · Stock Option (right to buy) | +94,031 | 94,031 | ||
| 2019-07-22 | Shukla Sath EVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2019-06-13 | Hagen Heidi Director | Grant or award · Stock Option (right to buy) | +93,922 | 93,922 | ||
| 2019-05-07 | CANNON JAMES ANTHONY Director | Option exercise | +15,000 | $0.70 | $11K | 398,050 |
Page 9 of 16 · 304 trades